MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease
Abstract Background Matrix metallopeptidase 9 (MMP9) has been implicated in a variety of neurological disorders, including Alzheimer’s disease (AD), where MMP9 levels are elevated in the brain and cerebrovasculature. Previously our group demonstrated apolipoprotein E4 (apoE4) was less efficient in r...
Main Authors: | Charis Ringland, Jonas Elias Schweig, Maxwell Eisenbaum, Daniel Paris, Ghania Ait-Ghezala, Michael Mullan, Fiona Crawford, Laila Abdullah, Corbin Bachmeier |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Neuroscience |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12868-021-00643-2 |
Similar Items
-
Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy
by: Joseph O. Ojo, et al.
Published: (2021-05-01) -
Association of the MMP-3, MMP-9 and MMP-12 gene polymorphisms with COPD risk: a meta-analysis
by: Hua Zhao, et al.
Published: (2021-03-01) -
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
by: Daniel Paris, et al.
Published: (2013-01-01) -
Immunoexpression of MMP-8 and MMP-9 in chronic subdural hematoma
by: Gao-Jian Su, et al.
Published: (2022-08-01) -
Serum amyloid A and pairing formyl peptide receptor 2 are expressed in corneas and involved in inflammation-mediated neovascularization
by: Sheng-Wei Ren, et al.
Published: (2014-04-01)